The infectious-disease expert, elevated to chief presidential medical adviser by Biden in 2021, has said he will be stepping down from both his position in the Biden administration and as director of the National Institute of Allergy and Infectious Diseases at the end of the year.
More Stories
Stocks poised for first September gain in 5 years. Why more good times could lie ahead.
September has historically been the worst month for U.S. stocks — but not this year
This mortgage hack could save you thousands a year — and it’s not a refinance
Homeowners looking to leverage lower mortgage rates can ask their lenders for a “rate modification,” financial experts say.
Diversify your 401(k) with these cheap investments that nobody else wants right now
It’s rescued investors in the past from a lost decade
Stock investors face a gut-wrenching 3 months ahead after record market run
‘There’s this debate between a hard landing, a soft landing or no landing that continues,’ says Lerner at Truist Advisory...
Gold’s record rally gets added jolt from Fed rate cut. Is there anyone left to buy?
Some analysts warn the pool of potential gold buyers could begin to run dry.
Intel’s stock seals strong week. But would a Qualcomm merger make sense?
One fund manager sees “more cons than pros” if the companies were to combine, after the Wall Street Journal reported...